FI932680A - Fusionspolypeptider - Google Patents

Fusionspolypeptider Download PDF

Info

Publication number
FI932680A
FI932680A FI932680A FI932680A FI932680A FI 932680 A FI932680 A FI 932680A FI 932680 A FI932680 A FI 932680A FI 932680 A FI932680 A FI 932680A FI 932680 A FI932680 A FI 932680A
Authority
FI
Finland
Prior art keywords
fusionspolypeptider
Prior art date
Application number
FI932680A
Other languages
Finnish (fi)
Other versions
FI932680A0 (en
Inventor
Teresa M Kubiak
Satish K Sharma
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI932680A publication Critical patent/FI932680A/en
Publication of FI932680A0 publication Critical patent/FI932680A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
FI932680A 1990-12-13 1993-06-11 Fusionspolypeptider FI932680A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62672790A 1990-12-13 1990-12-13

Publications (2)

Publication Number Publication Date
FI932680A true FI932680A (en) 1993-06-11
FI932680A0 FI932680A0 (en) 1993-06-11

Family

ID=24511577

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932680A FI932680A0 (en) 1990-12-13 1993-06-11 Fusionspolypeptider

Country Status (13)

Country Link
EP (1) EP0561971A1 (en)
JP (1) JPH06503473A (en)
AU (1) AU662508B2 (en)
CA (1) CA2094512A1 (en)
CZ (1) CZ109393A3 (en)
FI (1) FI932680A0 (en)
HU (1) HUT69963A (en)
IE (1) IE914347A1 (en)
NO (1) NO932148L (en)
RU (1) RU2114119C1 (en)
SK (1) SK60893A3 (en)
TW (1) TW213923B (en)
WO (1) WO1992010576A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
JP2000350590A (en) * 1999-04-12 2000-12-19 Pfizer Prod Inc Growth hormone and growth hormone releasing hormone composition
US6759393B1 (en) 1999-04-12 2004-07-06 Pfizer Inc. Growth hormone and growth hormone releasing hormone compositions
WO2001036643A1 (en) * 1999-11-19 2001-05-25 Transkaryotic Therapies, Inc. Nucleic acid construct for optimized production of products
EP1205551A1 (en) * 2000-11-09 2002-05-15 Pfizer Products Inc. Growth hormone and growth hormone releasing hormone compositions
JP4865565B2 (en) 2003-12-09 2012-02-01 ノヴォ ノルディスク アー／エス Controlling food selection using GLP-1 agonists
EP1758575A1 (en) 2004-06-11 2007-03-07 Novo Nordisk A/S Counteracting drug-induced obesity using glp-1 agonists
US8404637B2 (en) 2005-02-11 2013-03-26 Amylin Pharmaceuticals, Llc GIP analog and hybrid polypeptides with selectable properties
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
SI2402754T2 (en) † 2006-03-06 2023-09-29 Amunix Operating Inc. Unstructured recombinant polymers and uses thereof
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
CA2748314C (en) 2009-02-03 2018-10-02 Amunix Operating Inc. Extended recombinant polypeptides and compositions comprising same
AU2010290131C1 (en) 2009-08-24 2015-12-03 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
EP2528935B1 (en) 2010-01-29 2019-03-27 Archer-Daniels-Midland Company Peptide domains that bind small molecules of industrial significance
DK2822577T3 (en) 2012-02-15 2019-04-01 Bioverativ Therapeutics Inc RECOMBINANT FACTOR VIII PROTEINS
ES2771208T3 (en) 2012-02-15 2020-07-06 Bioverativ Therapeutics Inc Factor VIII compositions and methods of preparation and use thereof
WO2015023891A2 (en) 2013-08-14 2015-02-19 Biogen Idec Ma Inc. Factor viii-xten fusions and uses thereof
WO2017024060A1 (en) 2015-08-03 2017-02-09 Biogen Ma Inc. Factor ix fusion proteins and methods of making and using same
JP7046990B2 (en) * 2017-06-29 2022-04-04 ユレカ・ソシエテ・ア・レスポンサビリテ・リミテ Prodrug peptide with improved medicinal properties
NZ769677A (en) 2018-05-18 2024-07-05 Bioverativ Therapeutics Inc Methods of treating hemophilia a

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703004A (en) * 1984-01-24 1987-10-27 Immunex Corporation Synthesis of protein with an identification peptide
US4569794A (en) * 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
ES2063360T3 (en) * 1989-06-16 1995-01-01 Upjohn Co POWERFUL GRF ANALOGS, STABILIZED.
ATE139572T1 (en) * 1990-04-09 1996-07-15 Upjohn Co METHOD FOR PURIFYING RECOMBINANT PROTEINS AND USEFUL PRODUCTS THEREFOR

Also Published As

Publication number Publication date
HUT69963A (en) 1995-09-28
NO932148L (en) 1993-08-09
WO1992010576A1 (en) 1992-06-25
NO932148D0 (en) 1993-06-11
AU9116591A (en) 1992-07-08
JPH06503473A (en) 1994-04-21
SK60893A3 (en) 1993-10-06
TW213923B (en) 1993-10-01
EP0561971A1 (en) 1993-09-29
CA2094512A1 (en) 1992-06-14
HU9301705D0 (en) 1993-10-28
CZ109393A3 (en) 1994-01-19
FI932680A0 (en) 1993-06-11
RU2114119C1 (en) 1998-06-27
IE914347A1 (en) 1992-06-17
AU662508B2 (en) 1995-09-07

Similar Documents

Publication Publication Date Title
FI932069A0 (en) INJEKTIONSSPRUTA
FI924473A (en) HAORFOERMNINGSSCHAMPO
ATA150090A (en) HOERGERAET
DK0439279T3 (en) Borerørs- / foringsbeskyttelsesorgan
FI931369A (en) FLYTANDE DETERGENTKOMPOSITIONER
FI925594A (en) FOTOGRAFISERIE
FI931964A0 (en) BRYNINGSKOMPOSITION
NO913927D0 (en) SKJAEREVERKTOEY
FI932680A0 (en) Fusionspolypeptider
FI924391A (en) AMINOPEROXYYRA INNEHAOLLANDE BLEKNINGSGRANULAT
ATA210290A (en) LOTPILLE
NO914584L (en) Aminodiol-DERIVATIVES
FI931934A0 (en) DEXTROMETORFANINNEHAOLLANDE HOSTMEDICINKOMPOSITIONER
FI924628A (en) SUPRALEDNINGSKABEL
ATA80690A (en) ALPINSCHI
ATA200090A (en) PIANINO
FI932807A0 (en) Braensleelement Foer kaerneactor
ATA209290A (en) DIARAEHMCHEN
BR9103647A (en) THIOESTERES
SE9102229D0 (en) SPAENNANORDNING
ATA237490A (en) RINNENSTEIN
FI88277C (en) Kassettflaksystem
SE9001658D0 (en) UNIVERSALTRANSPORTKAERRA
SE9000733D0 (en) LAASPINNE
BR7000495U (en) LIFE-BREAKER

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY

FD Application lapsed